However, our data demonstrated that the efficacy of PD-1/PD-L1 blockade in preventing immune decay and tumor rejection significantly diminished in Lect2−/− mice, suggesting multiple immunological brakes need to be lifted to augment the effective immune system response against EOC. Here, PDCD1 is linked to neoplasm.